Yimimde Tinea Versicolor Relief

Generic Name: yimimde tinea versicolor relief

Over-the-Counter (OTC)

Brand Names:

Uses Helps relieve dryness, itching, redness, and discomfort caused by eczema-prone skin.

Overview

Uses Helps relieve dryness, itching, redness, and discomfort caused by eczema-prone skin.

Uses

First, wet your skin. Then lather the soap in your hands, and apply the lather to your face or body in a circular motion. Leave on skin fortwo minutes, then rinse completely and pat dry gently.

Dosage

Dosage and administration First, wet your skin. Then lather the soap in your hands, and apply the lather to your face or body in a circular motion. Leave on skin for two minutes, then rinse completely and pat dry gently.

Side Effects

Stop use Stop use and ask a doctor if rash or irritation appears or if any adverse reactions occur

Interactions

Ask a doctor Stop use and ask a doctor if rash or irritation appears or if any adverse reactions occur

Warnings

Warnings For external use only

Storage

Other information Store at room temperature.

Frequently Asked Questions

What is Yimimde Tinea Versicolor Relief used for?▼

First, wet your skin. Then lather the soap in your hands, and apply the lather to your face or body in a circular motion. Leave on skin fortwo minutes, then rinse completely and pat dry gently.

What are the side effects of Yimimde Tinea Versicolor Relief?▼

Stop use Stop use and ask a doctor if rash or irritation appears or if any adverse reactions occur

What are the important warnings for Yimimde Tinea Versicolor Relief?▼

Warnings For external use only

Related Medications

Relacorilant

relacorilant

Dosage form: POWDER. Active ingredients: RELACORILANT (1 kg/kg). Category: BULK INGREDIENT.

Avobenzone, Homosalate, Octisalate, Octocrylene, White Petrolatum

avobenzone, homosalate, octisalate, octocrylene, white petrolatum

Purposes Sunscreens Skin protectant

Ravulizumab

ravulizumab

Complement Inhibitor [EPC]

11 DESCRIPTION Ravulizumab-cwvz, a complement inhibitor, is a humanized monoclonal antibody (mAb) produced in Chinese hamster ovary (CHO) cells. Ravulizumab-cwvz consists of 2 identical 448 amino acid heavy chains and 2 identical 214 amino acid light chains and has a molecular weight of approximately 148 kDa. The constant regions of ravulizumab-cwvz include the human kappa light chain constant region, and the protein engineered "IgG2/4" heavy chain constant region.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.